International Isotopes Inc (INIS)
0.0364
0.00 (0.00%)
USD |
OTCM |
May 16, 13:40
International Isotopes Enterprise Value: 18.24M for May 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 18.24M |
| May 14, 2024 | 16.57M |
| May 13, 2024 | 16.78M |
| May 10, 2024 | 16.78M |
| May 09, 2024 | 16.05M |
| May 08, 2024 | 15.88M |
| May 07, 2024 | 14.44M |
| May 06, 2024 | 19.38M |
| May 03, 2024 | 15.04M |
| May 02, 2024 | 19.49M |
| May 01, 2024 | 19.64M |
| April 30, 2024 | 21.72M |
| April 29, 2024 | 20.68M |
| April 26, 2024 | 21.70M |
| April 25, 2024 | 21.20M |
| April 24, 2024 | 21.20M |
| April 23, 2024 | 21.46M |
| April 22, 2024 | 21.46M |
| April 19, 2024 | 20.68M |
| April 18, 2024 | 20.16M |
| April 17, 2024 | 19.12M |
| April 16, 2024 | 18.60M |
| April 15, 2024 | 17.56M |
| April 12, 2024 | 17.04M |
| April 11, 2024 | 17.56M |
| Date | Value |
|---|---|
| April 10, 2024 | 20.16M |
| April 09, 2024 | 18.60M |
| April 08, 2024 | 20.16M |
| April 05, 2024 | 15.48M |
| April 04, 2024 | 18.13M |
| April 03, 2024 | 20.68M |
| April 02, 2024 | 21.15M |
| April 01, 2024 | 19.17M |
| March 28, 2024 | 20.42M |
| March 27, 2024 | 20.68M |
| March 26, 2024 | 19.63M |
| March 25, 2024 | 20.15M |
| March 22, 2024 | 20.67M |
| March 21, 2024 | 20.67M |
| March 20, 2024 | 22.75M |
| March 19, 2024 | 21.71M |
| March 18, 2024 | 22.23M |
| March 15, 2024 | 22.75M |
| March 14, 2024 | 22.75M |
| March 13, 2024 | 22.75M |
| March 12, 2024 | 22.75M |
| March 11, 2024 | 22.75M |
| March 08, 2024 | 22.75M |
| March 07, 2024 | 22.75M |
| March 06, 2024 | 22.75M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.08M
Minimum
Oct 10 2022
121.61M
Maximum
Jan 19 2021
33.66M
Average
28.41M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.622M |
| Palatin Technologies Inc | 23.92M |
| iBio Inc | 16.42M |
| Theriva Biologics Inc | -8.896M |
| Oragenics Inc | 5.761M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.1091M |
| Revenue (Quarterly) | 3.147M |
| Total Expenses (Quarterly) | 3.238M |
| EPS Diluted (Quarterly) | -0.0002 |
| Gross Profit Margin (Quarterly) | 62.40% |
| Profit Margin (Quarterly) | -3.47% |
| Earnings Yield | -4.61% |
| Normalized Earnings Yield | -4.613 |